This company listing is no longer active
Zymergen Past Earnings Performance
Past criteria checks 0/6
Key information
-13.0%
Earnings growth rate
68.1%
EPS growth rate
Chemicals Industry Growth | 12.9% |
Revenue growth rate | -22.1% |
Return on equity | -154.2% |
Net Margin | -2,503.0% |
Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
Recent updates
Zymergen chief scientific officer to depart as company lays off more employees
Aug 25Zymergen: Ginkgo Bioworks Acquisition
Jul 26Zymergen expands agreement with Octant on developing breakthrough medicines
Jul 14Zymergen Seeks Turnaround But Runway Is Running Low
Jun 03Zymergen: A Humbled Company With A Business On The Ropes
May 23Some Zymergen Inc. (NASDAQ:ZY) Analysts Just Made A Major Cut To Next Year's Estimates
Mar 27Zymergen Inc. (NASDAQ:ZY) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mar 25Zymergen: Total Chaos
Dec 09Zymergen: How To Buy A Disaster
Aug 05Analysts Just Made A Major Revision To Their Zymergen Inc. (NASDAQ:ZY) Revenue Forecasts
Aug 05Zymergen acquired Accelerator Life Science Partners’ portfolio company
May 28Revenue & Expenses BreakdownBeta
How Zymergen makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 22 | 15 | -365 | 104 | 0 |
31 Mar 22 | 18 | -349 | 107 | 0 |
31 Dec 21 | 17 | -362 | 106 | 0 |
30 Sep 21 | 20 | -359 | 98 | 0 |
30 Jun 21 | 19 | -323 | 95 | 0 |
31 Mar 21 | 14 | -281 | 85 | 0 |
31 Dec 20 | 13 | -262 | 78 | 0 |
31 Dec 19 | 15 | -237 | 85 | 0 |
Quality Earnings: ZY is currently unprofitable.
Growing Profit Margin: ZY is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ZY's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare ZY's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ZY is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (20.9%).
Return on Equity
High ROE: ZY has a negative Return on Equity (-154.22%), as it is currently unprofitable.